Associated tags: Patient, MDO, NYSE, Integer, Conference
Locations: CLARENCE, NY, US, TEXAS, IRELAND, EUROPEAN UNION, NEW YORK, NEVADA
Electrode,
IPG,
Exhibition,
HRS,
Heart Rhythm,
Integer,
Original equipment manufacturer,
Microelectrode,
CDMO,
Acquisition,
Electrophysiology,
HSR,
Medical device Some examples include market-leading battery technology, finished leads and implantable pulse generators (IPG) for cardiac applications.
Key Points:
- Some examples include market-leading battery technology, finished leads and implantable pulse generators (IPG) for cardiac applications.
- Integer is a leading manufacturer of access and complex catheter access solutions in electrophysiology, including guidewires, transseptal access, diagnostic and ablation technology platforms.
- Those attending HRS will discover how Integer’s recent strategic investments, particularly the acquisition of Pulse Technologies, are reshaping how Integer serves the world’s leading medical device OEMs and start-ups.
- These innovations significantly enhance the performance and reliability of medical devices across cardiac rhythm management, neuromodulation, and cardiovascular applications.
PLANO, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended March 29, 2024.
Key Points:
- PLANO, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended March 29, 2024.
- First Quarter 2024 Highlights (compared to First Quarter 2023, except as noted)
Sales increased 10% to $415 million, with organic growth of 6%.
- Cardiac Rhythm Management & Neuromodulation sales increased 8% in the first quarter 2024 compared to the first quarter 2023, with strong growth in emerging Neuromodulation customers with PMA (pre-market approval) products and strong demand in Cardiac Rhythm Management.
- Electrochem sales decreased in the first quarter 2024 compared to the first quarter 2023, returning to a normalized run-rate after previously higher sales from the supply chain recovery.
PLANO, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2024, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 25, 2024.
Key Points:
- PLANO, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2024, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 25, 2024.
- Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m.
- The conference call will also be available live or via archived replay on the Investor Relations section of the Integer website at: investor.integer.net .
- To automatically receive Integer financial news by email, please visit investor.integer.net and subscribe to email alerts.
PLANO, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that Joe Dziedzic, President and Chief Executive Officer, will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum at 11:15 a.m.
Key Points:
- PLANO, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that Joe Dziedzic, President and Chief Executive Officer, will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum at 11:15 a.m.
- ET on Tuesday, March 19, 2024.
Retrieved on:
Thursday, February 15, 2024
Acquisition,
NPV,
PMA,
Integer,
Growth,
Electrophysiology,
GAAP,
C&V,
CRM,
EPS,
Electrochemistry PLANO, Texas, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three and twelve months ended December 31, 2023. Unless otherwise stated, all results and comparisons are from continuing operations.
Key Points:
- PLANO, Texas, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three and twelve months ended December 31, 2023.
- Fourth Quarter 2023 Financial Results (compared to fourth quarter 2022, except as noted)
Sales increased 11% to $413 million.
- Cardiac Rhythm Management & Neuromodulation sales increased 7% in the fourth quarter 2023 compared to fourth quarter 2022, with double-digit growth in Neuromodulation, driven by strong demand from emerging customers with PMA (pre-market approval) products.
- Electrochem sales decreased 42% in the fourth quarter 2023 compared to fourth quarter 2022, returning to a normalized run-rate after previously higher sales from the supply chain recovery.
Retrieved on:
Thursday, February 1, 2024
Neuromodulation,
Electrophysiology,
MD,
Integer,
Patient,
Gen,
Second generation,
Anaheim Convention Center,
Risk,
Acquisition,
Cardio,
Arrhythmia,
Blood vessel,
Medical imaging PLANO, Texas, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leader in medical device outsource manufacturing, will join innovators and industry leaders around the world in exhibiting at MD&M West, Feb. 6-8, 2024, at the Anaheim Convention Center in Anaheim, California.
Key Points:
- Integer’s exhibit will spotlight the recent strategic acquisitions of InNeuroCo and Pulse Technologies, each of which have further enhanced Integer’s capability spectrum in the medical device sector.
- The acquisition of InNeuroCo brings specific expertise in neurovascular solutions and advanced catheter technologies, while the combination with Pulse Technologies enhances capabilities in precision micro machining, backed by proprietary technologies and a focus on high-growth medical markets.
- Cardio and Vascular Solutions: A full range of electrophysiology, structural heart, and neurovascular product solutions including high-performing guidewires, steerable introducers and sheaths, therapy delivery systems, and implant technologies.
- In addition to Integer’s exhibit at booth #1439, MD&M West 2024 attendees can also visit Pulse Technologies at booth #2844 to learn more about complex micro machining for critical medical device components.
Retrieved on:
Tuesday, January 16, 2024
PLANO, Texas, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will join medtech leaders and innovators around the world in exhibiting at the North American Neuromodulation Society (NANS) Annual Meeting at Caesars Palace in Las Vegas from Jan. 18 – 21, 2024.
Key Points:
- PLANO, Texas, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will join medtech leaders and innovators around the world in exhibiting at the North American Neuromodulation Society (NANS) Annual Meeting at Caesars Palace in Las Vegas from Jan. 18 – 21, 2024.
- During NANS, attendees are invited to visit booth #127 to learn more about Integer’s latest innovations and expanded capabilities in neuromodulation to enable the next generation of miniaturized active implantable devices.
- “Through miniaturization, Integer is creating the next generation of differentiated platform technologies to accelerate and de-risk OEMs’ path to market for novel implantable medical devices,” said Jim Stephens, President, CRM&N.
- Xcellion Gen 3 FC delivers best in class battery runtime and full re-charges in as little as 30 minutes.
Retrieved on:
Wednesday, January 10, 2024
Electrophysiology,
Patient,
NPV,
Central Time,
Adjustment,
GAAP,
Acquisition,
Conference,
Medtech,
Depreciation,
Engineering,
Integer,
Growth PLANO, Texas, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced fourth quarter 2023 preliminary unaudited sales are expected to be in the range of $411 million to $413 million, an increase of 10% to 11% compared to fourth quarter 2022. Preliminary unaudited full year 2023 sales are expected to be in the range of $1.595 billion to $1.597 billion, an increase of 16% compared to full year 2022.
Key Points:
- Based in Quakertown, Pennsylvania, Pulse Technologies also provides proprietary advanced technologies, including Hierarchical Surface Restructuring (HSR™), Scratch-Free Surface Finishes, and Titanium Nitride Coatings.
- “The acquisition of Pulse Technologies is directly aligned with Integer’s strategy to expand our capabilities and capacity in targeted growth markets,” said Payman Khales, Integer President, Cardio & Vascular.
- “We were immediately impressed with Pulse Technologies’ long-standing customer relationships, technical talent, unique technologies, shared values, and capacity for growth.
- Pulse Technologies’ estimated full year 2023 sales are approximately $42 million with 2023 adjusted EBITDA(a) expected to be approximately $11 million.
Retrieved on:
Wednesday, January 3, 2024
PLANO, Texas, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced participation in the upcoming 42nd Annual J.P. Morgan Healthcare Conference to be held in San Francisco from Jan 8-11, 2024.
Key Points:
- PLANO, Texas, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced participation in the upcoming 42nd Annual J.P. Morgan Healthcare Conference to be held in San Francisco from Jan 8-11, 2024.
- Joseph Dziedzic, President and Chief Executive Officer, is scheduled to present on Wednesday, Jan. 10, 2024, at 4:30 p.m. PT (7:30 p.m.
- ET).
Retrieved on:
Thursday, November 16, 2023
PLANO, Texas, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced participation in the upcoming Piper Sandler 35th Annual Healthcare Conference to be held in New York City from Nov. 28–30, 2023.
Key Points:
- PLANO, Texas, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced participation in the upcoming Piper Sandler 35th Annual Healthcare Conference to be held in New York City from Nov. 28–30, 2023.
- Joseph Dziedzic, President and Chief Executive Officer, is scheduled to present on Wednesday, Nov. 29, 2023, at 10:00 a.m. EST.
- The link to the live webcast may also be accessed under “News & Events” on the Investor Relations section of the Integer website at investor.integer.net .
- A replay of the webcast will be available on the company’s website for approximately three months.
